|

MVR-C5252 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

  • Duke University1

Indications

  • Recurrent High Grade Glioma1
  • Cancer1

New York, New York1 trial

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

Memorial Sloan Kettering

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.